Use of antiepileptic drugs (AEDs) is usually unavoidable for pregnant epileptic women to control seizure activity but is associated with a greater risk of major congenital malformation ([@r1]) and behavioral disorder in the offspring ([@r2]). Thus, the risk associated with the treatment is a major concern to women of childbearing age suffering from epilepsy. The AED valproic acid (VPA) is used worldwide and reportedly prescribed to more than 20% of pregnant women afflicted with epilepsy ([@r1], [@r3]). Accumulating epidemiological studies indicate that prenatal VPA exposure increases the risk of congenital malformations ([@r4]) and can have a long-lasting effect on brain function of children born to epileptic mothers ([@r5], [@r6]). Maternal use of VPA during pregnancy correlates with a significantly increased risk of autism spectrum disorder ([@r7]) and attention-deficit/hyperactivity disorder ([@r8]) in the offspring, both of which are known to often coincide with seizure disorders including epilepsy ([@r9], [@r10]). Further investigation is therefore warranted to reveal the basis of the correlation between maternal use of VPA and increased susceptibility to seizure in the offspring.

The adult mammalian brain retains neural stem/progenitor cells (NS/PCs) in the subgranular zone (SGZ) of the hippocampal dentate gyrus (DG), and these NS/PCs continuously generate new neurons throughout life ([@r11]). Newborn neurons migrate, settle in the granular cell layer (GCL), and eventually become mature granular cells (GCs). Accurate migration of newborn neurons in the adult DG is critical for physiological hippocampal functions, and thus their mislocalization often leads to neuronal dysfunction through the formation of abnormal neuronal circuits ([@r12]). In this context, GCs ectopically located in the dentate hilus have been shown to be more excitable than those located normally in the GCL ([@r13], [@r14]); such ectopic neurons are frequently observed in animal models as well as in patients with temporal lobe epilepsy, which is the most common form of epilepsy in adults ([@r15][@r16]--[@r17]).

Previous reports have identified several genes ([@r18][@r19]--[@r20]), including *CXC motif chemokine receptor 4* (*Cxcr4*) ([@r21]), as being responsible for the appropriate localization of newborn neurons in the adult hippocampal DG. Cxcr4 is a G protein-coupled receptor whose ligand is the chemoattractant Cxcl12 ([@r22]). In the adult hippocampal DG, Cxcr4 is expressed in NS/PCs and immature neurons, whereas Cxcl12 is expressed in GCs ([@r23], [@r24]).

In this study, we investigated the correlation between maternal use of VPA and increased seizure susceptibility in the offspring using a mouse model. Mechanistically, prenatal VPA exposure changed the property of adult hippocampal NS/PCs at the transcriptome level, for example by downregulating *Cxcr4*, and consequently increased the ectopic localization of newborn neurons in the hilus. Furthermore, we found that these adverse effects of embryonic VPA exposure were offset by voluntary exercise in a running wheel and that increased expression of *Cxcr4* in hippocampal NS/PCs alone could recapitulate the effect of the exercise.

Results {#s1}
=======

Prenatal VPA Exposure Increases Seizure Susceptibility and Ectopic Hippocampal Neurogenesis in Adult Mice. {#s2}
----------------------------------------------------------------------------------------------------------

To explore the correlation between maternal use of VPA and increased susceptibility to seizure in the offspring using a mouse model, we first administered kainic acid (KA), a chemoconvulsant that activates glutamate receptors, to 12-wk-old (12w), prenatally VPA-exposed mice (VPA mice) ([Fig. 1*A*](#fig01){ref-type="fig"}). VPA mice developed more severe seizures than controls ([Fig. 1*B*](#fig01){ref-type="fig"}), indicating that prenatal VPA exposure increases seizure susceptibility in adulthood. Since pharmacological and genetic deletion of GABAergic interneurons in the hippocampus is reportedly associated with increased seizure susceptibility and epilepsy in mice ([@r25], [@r26]), we assessed the numbers of parvalbumin (PV)-, somatostatin (SST)-, and calretinin (CR)-positive interneurons in the hippocampus of control and VPA mice and found that they were comparable between the two groups ([Fig. S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)). We then focused on adult neurogenesis from NS/PCs in the SGZ of the hippocampal DG, because, as mentioned above, abnormal neuronal migration and subsequent generation of ectopic GCs (EGCs) are known to associate with epileptogenesis, in mice as well as humans. In the DG of VPA mice, the number of DCX-positive immature neurons located within the SGZ/GCL was lower than that in control mice ([Fig. 1 *C* and *D*](#fig01){ref-type="fig"}), indicating decreased adult hippocampal neurogenesis in VPA mice, in agreement with our previous study ([@r27]). Intriguingly, we discovered that the numbers of both DCX-positive immature and GC marker Prox1-positive neurons located ectopically in the hilus were increased in VPA mice ([Fig. 1 *C* and *E*--*G*](#fig01){ref-type="fig"}). These data imply that abnormal neuronal migration in the DG of VPA mice is associated with higher susceptibility to seizure.

![Prenatal exposure to VPA increases seizure susceptibility and ectopic hippocampal neurogenesis in the adult. (*A*) Experimental scheme for investigating seizure susceptibility and adult neurogenesis. Control \[administered with methylcellulose (MC)\] and VPA mice were randomly assigned to the groups for scoring of seizure severity and immunohistochemistry (IHC). (*B*) Seizure response to KA treatment over time in control and VPA mice (*n* = 6 animals each). Two-way repeated measures ANOVA was used for statistical analysis (treatment: *F*~1,130~ = 59.08, *P* \< 0.0001; time: *F*~12,130~ = 7.063, *P* \< 0.0001; treatment × time interaction: *F*~12,130~ = 2.341, *P* = 0.0095, post hoc Bonferroni's multiple comparison test). (*C*) Representative images of DCX-positive (cyan) immature neurons in the DG. The area outlined by a white rectangle in the lower main panel is enlarged to the right. The arrow indicates a DCX-labeled cell in the hilus, and dashed white lines mark the boundaries between GCL and hilus. (*Insets*) H33258 nuclear staining of each field. (Scale bar, 200 µm.) (*D* and *E*) Quantification of the number of DCX-positive cells in the SGZ/GCL (*D*) and hilus (*E*) (*n* = 4 animals each). (*F*) Representative images of Prox1-positive (red) GCs in the DG. The area outlined by a white rectangle in the lower main panel is enlarged to the right. The arrow indicates a Prox1-positive cell in the hilus, and the dashed white line marks the boundary between GCL and hilus. (*Insets*) H33258 nuclear staining (gray) of each field. (Scale bar, 200 µm.) (*G*) Quantification of the number of Prox1-positive cells in the hilus (*n* = 3 animals each). \**P* ≤ 0.05, \*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001.](pnas.1716479115fig01){#fig01}

Developmental Stage-Dependent Gene Expression Differences in NS/PCs Between Control and VPA Mice. {#s3}
-------------------------------------------------------------------------------------------------

To gain a deeper insight into how prenatal VPA exposure induces aberrant and/or ectopic neurogenesis in the adult DG, we performed RNA sequencing using EGFP-positive NS/PCs isolated from *Nestin*-EGFP mice with or without prenatal VPA exposure. NS/PCs were isolated from forebrain (E15) to investigate the acute effect of VPA and from the DG \[postnatal day (P) 5 and 12w\] to explore the long-term effects of VPA on the developing ([@r28]) and mature DG ([Fig. 2*A*](#fig02){ref-type="fig"}). Hierarchical clustering identified three distinct clusters, each composed of NS/PCs derived from a single developmental stage ([Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)), suggesting that prenatal VPA exposure did not affect gene expression in NS/PCs as strongly as it intermingles the clustering between distinct developmental stages. Therefore, we next sought to identify differentially expressed genes (DEGs), whose expression levels were significantly changed by VPA exposure within each developmental stage (q-value \< 0.05, fold change ≥ 1.5). In NS/PCs derived from E15 mice, most of the DEGs were up-regulated genes (235 out of all 248 DEGs), most likely because VPA is a histone deacetylase inhibitor ([@r29]) that positively regulates gene expression by promoting histone acetylation ([Fig. 2*B*](#fig02){ref-type="fig"}). Furthermore, gene set enrichment analysis (GSEA) using the E15 NS/PC transcriptome revealed a significant increase in the expression of neuron differentiation- and nervous system development-related genes in VPA mice compared with control, suggesting that VPA promotes the differentiation of NS/PCs into neurons ([Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)), in accordance with previous reports ([@r27], [@r30]).

![Transcriptome analysis of NS/PCs from control and VPA mice at distinct developmental stages. (*A*) Schematic representation of the isolation of NS/PCs from Ctrl and VPA mice at E15, P5, and 12w. RNAs were extracted from these cells and subjected to sequence analysis. (*B*) Scatter plots of genes expressed in NS/PCs from Ctrl and VPA mice. Up- (red) and down-regulated (blue) DEGs are highlighted. (*C* and *D*) Venn diagrams of up- (*C*) and down-regulated (*D*) DEGs at each developmental stage. (*E* and *F*) Box plot of up- (*E*) and down-regulated (*F*) DEG expression in NS/PCs of 12w hippocampal DG. In contrast to 12w, expression levels of the DEGs are comparable between Ctrl and VPA mice at E15 and P5. \*\*\**P* ≤ 0.001. n.s., not significant.](pnas.1716479115fig02){#fig02}

We then asked whether these gene expression changes in E15 NS/PCs induced by VPA exposure are sustained in hippocampal NS/PCs at P5 and 12w. Among up- and down-regulated DEGs at each developmental stage, only one DEG persisted throughout these stages ([Fig. 2 *C* and *D*](#fig02){ref-type="fig"}). These data indicate that prenatal VPA exposure initially triggers differential gene expression in NS/PCs, but that the identity of the DEGs changes as development progresses. In support of this, when we examined the DEGs identified in NS/PCs of 12w mice at the earlier developmental stages (E15 and P5), we observed no differences in their expression between control and VPA mice ([Fig. 2 *E* and *F*](#fig02){ref-type="fig"}).

Prenatal VPA Exposure Leads to Perturbation in the Expression of Cell Migration-Associated Genes in Adult NS/PCs. {#s4}
-----------------------------------------------------------------------------------------------------------------

Having observed that aberrant neurogenesis occurs in 12w VPA mice, we hypothesized that genes responsible for this impairment would be among the DEGs in 12w NS/PCs. To identify such genes, we subjected DEGs in 12w NS/PCs to Gene Ontology (GO) analysis of biological processes and found that both up-regulated and down-regulated genes are significantly associated with two cell migration-related terms, "cell adhesion" and "positive regulation of cell migration" ([Fig. 3 *A* and *B*](#fig03){ref-type="fig"}). Among the genes categorized in these GO terms, we next asked whether they overlapped with genes in the GO term "neuron migration," since we are focusing on neuronal mislocalization ([Fig. 3 *C* and *D*](#fig03){ref-type="fig"}), and identified two down-regulated genes that did so, contactin 2 (*Cntn2*) and *Cxcr4* ([Fig. 3 *D* and *E*](#fig03){ref-type="fig"}). *Cntn2* encodes one of the members of the contactin family, which are reported to modulate the migration of cortical interneurons in embryonic brain ([@r31]), although no role has hitherto been shown for Cntn2 in adult neurogenesis. In contrast, the conditional deletion of *Cxcr4* in NS/PCs has been shown to induce ectopic positioning of newborn neurons in the adult hippocampus ([@r21]). Therefore, we decided to further focus on *Cxcr4* as a candidate contributor to the aberrant neuronal migration and enhanced seizure sensitivity in VPA mice in the following experiments.

![Prenatal VPA exposure alters the expression level of cell migration-related genes in NS/PCs of adult DG. (*A* and *B*) Functional annotation of up- (*A*) and down-regulated (*B*) genes in NS/PCs of adult VPA mice relative to control mice. The top five GO terms in each gene group are displayed. (*C*) Venn diagram of up-regulated genes categorized in the GO term "cell adhesion" and the gene list associated with "neuron migration." There was no overlap between genes in each category. (*D*) Identification of two candidate genes for the ectopic neuronal migration in VPA mice at 12w. Down-regulated genes categorized in the GO terms "cell adhesion" or "positive regulation of cell migration" overlapped with two genes in the GO term "neuron migration." (*E*) Expression levels of the two genes identified in *D*.](pnas.1716479115fig03){#fig03}

Voluntary Exercise Ameliorates Enhanced Seizure Susceptibility and Abnormal Neuronal Migration in VPA Mice by Normalizing Perturbed Gene Expression in NS/PCs. {#s5}
--------------------------------------------------------------------------------------------------------------------------------------------------------------

Voluntary exercise in a running wheel, a widely accepted neurogenic stimulus ([@r32], [@r33]), decreases seizure susceptibility in rats ([@r34][@r35]--[@r36]), although the mechanism underlying this effect is unknown. Therefore, we next evaluated the effect of this physical activity on seizure susceptibility and neuronal migration in the hippocampus in VPA mice ([Fig. 4*A*](#fig04){ref-type="fig"}). We found that 8 wk of voluntary running alleviated the time-dependent increase of seizure score in VPA mice to the level in control mice ([Fig. 4*B*](#fig04){ref-type="fig"}), coincident with decreased abnormal neuronal migration ([Fig. 4 *C* and *D*](#fig04){ref-type="fig"}).

![Voluntary exercise alleviates increased seizure susceptibility and abnormal neuronal migration in VPA mice. (*A*) Experimental scheme for investigating the effect of voluntary running on seizure susceptibility and neuronal migration in the DG. Control (administered with MC) and VPA mice were randomly assigned to the groups for scoring of seizure severity and IHC. (*B*) Seizure response to KA treatment over time in control and VPA mice with or without voluntary running as indicated (*n* = 6 animals each). Two-way repeated measures ANOVA was used for statistical analysis (treatment: *F*~3,240~ = 3.052, *P* = 0.0522; time: *F*~12,240~ = 9.837, *P* \< 0.0001; treatment × time interaction: *F*~36,240~ = 2.428, *P* \< 0.0001, post hoc Bonferroni's multiple comparison test for VPA vs. VPA+RW, \**P* ≤ 0.05, \*\**P* ≤ 0.01). (*C*) Representative images of DCX-positive immature neurons (cyan) in the DG. The area outlined by the white rectangle in the lower left is magnified in the inset. The arrow indicates a DCX-positive cell in the hilus, and the dashed white line marks the boundary between hilus and GCL. (*Insets*) H33258 nuclear staining (gray) of each field. (Scale bar, 200 µm.) (*D*) Quantification of the number of DCX-positive cells in the hilus (*n* = 5 animals each). One-way ANOVA was used for statistical analysis (*F*~3,16~ = 13.31, *P* \< 0.0001, post hoc Tukey's multiple comparison test, \*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001. n.s., not significant).](pnas.1716479115fig04){#fig04}

In light of these findings, we next attempted to examine the effects of voluntary running on the transcriptome profile of NS/PCs in VPA mice ([Fig. 5*A*](#fig05){ref-type="fig"}). To our surprise, the running mostly amended both positively and negatively distorted gene expression in the adult hippocampal NS/PCs of VPA mice ([Fig. 5*B*](#fig05){ref-type="fig"}). Of note, the altered expression of genes categorized as cell migration-related genes, including *Cxcr4*, in VPA mice was largely normalized by the physical activity ([Fig. 5 *C*--*E*](#fig05){ref-type="fig"}).

![Voluntary running normalizes transcriptomic alteration of adult NS/PCs in VPA mice. (*A*) Schematic representation of the isolation of NS/PCs from Ctrl and VPA mice at 12w. RNAs were extracted from these cells and subjected to sequence analysis. (*B*) Box plots of up- (*Left*) and down-regulated (*Right*) DEG expression in NS/PCs of 12w hippocampal DG. Changes of gene expression, in both directions, after VPA exposure were largely normalized by running (RW); \**P* ≤ 0.05, \*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001, n.s indicates not significant. (*C*) Heat map showing the expression level of up-regulated DEGs in adult VPA mice categorized in the GO term "cell adhesion" ([Fig. 2 *B* and *D*](#fig02){ref-type="fig"}) in control, VPA, and VPA+RW mice. (*D*) Heat map indicating the expression level of down-regulated genes in the adult VPA mice categorized in GO term "cell adhesion" and "positive regulation of cell migration" ([Fig. 2 *C* and *E*](#fig02){ref-type="fig"}) in control, VPA, and VPA+RW mice. (*E*) Expression level of *Cxcr4* in NS/PCs of 12w control, VPA, and VPA+RW mice.](pnas.1716479115fig05){#fig05}

Having observed that running suppressed abnormal neuronal migration and decreased seizure susceptibility and, even more interestingly, normalized the reduced expression of *Cxcr4* in VPA mice, we wanted to examine whether expression of *Cxcr4* alone in NS/PCs is capable of overcoming these prenatal VPA exposure-induced impairments. To do so, we used a retrovirus expressing *Cxcr4* together with *GFP* to selectively transduce proliferating NS/PCs in the DG. Before performing in vivo experiments, we first confirmed that infection by the *Cxcr4*-expressing virus can transduce NS/PCs to express Cxcr4 protein in vitro and found that it did so ([Fig. S3 *A* and *B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)). Since control and VPA mice at 4w displayed no difference yet in hippocampal neurogenesis or seizure susceptibility ([Fig. S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)), we infected hippocampal NS/PCs of VPA mice with control and *Cxcr4*-expressing retroviruses at this stage to examine the effect of *Cxcr4* expression 8 wk later ([Fig. 6*A*](#fig06){ref-type="fig"}). In the DG of these mice, newly generated mature neurons from NS/PCs were labeled with GFP and NeuN (a mature neuron marker) at 12w, 8 wk after the viral injection ([Fig. 6*A*](#fig06){ref-type="fig"} and [Fig. S3*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)). We found that restoration of *Cxcr4* expression reduced the mislocalization of GFP- and NeuN-positive newly generated neurons ([Fig. 6 *B* and *C*](#fig06){ref-type="fig"}). Although there was no significant interaction with time course, *Cxcr4* overexpression significantly decreased the seizure score induced by KA injection ([Fig. 6*D*](#fig06){ref-type="fig"}). These results indicate that replenishment of the reduced *Cxcr4* expression in NS/PCs of VPA mice is effective enough to prevent the aberrant neuronal migration in the DG and to counteract the aggravated seizure susceptibility caused by prenatal VPA exposure.

![Replenishment of *Cxcr4* expression in NS/PCs of the DG alleviates the increased seizure susceptibility and abnormal neuronal migration in VPA mice. (*A*) Experimental scheme for investigating the effect of *Cxcr4* expression in NS/PCs on seizure susceptibility and neuronal migration in VPA mice. (*B*) Representative images of GFP (green) and NeuN (red) dual-positive (GFP+NeuN+) newborn neurons located in the hilus (arrows). Dashed white lines indicate the boundary between hilus and GCL. (Scale bar, 20 µm.) (*C*) Quantification of percentages of the number of ectopically located GFP+NeuN+ cells among total GFP+NeuN+ cells in the DG (*n* = 5 animals each). (*D*) Seizure response to KA treatment over time in VPA mice that received control and *Cxcr4*-expressing retrovirus injection (*n* = 5 animals each). Two-way repeated measures ANOVA was used for statistical analysis (*Cxcr4*: *F*~1,104~ = 33.14, *P* \< 0.0001; time: *F*~12,104~ = 3.344, *P* = 0.0004; *Cxcr4* × time interaction: *F*~12,104~ = 0.5549, *P* = 0.8731). \**P* ≤ 0.05, \*\*\**P* ≤ 0.001.](pnas.1716479115fig06){#fig06}

Discussion {#s6}
==========

Accumulating evidence indicates that environmental insults including exposure to medical drugs in utero have long-lasting effects on brain function of the offspring ([@r37], [@r38]). In the present study, we have shown that prenatal VPA exposure impairs neuronal migration in the adult DG through the decreased expression of *Cxcr4* in NS/PCs and consequently increases seizure susceptibility, whereas voluntary running overcomes these adverse effects ([Fig. S5](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental)). Consistent with our findings, a previous study has proposed that the deletion of a chromosome region including the *Cxcr4* locus is strongly linked to a seizure disorder ([@r39]). However, further clinical research is needed to determine whether Cxcr4 deficiency and/or mutations are indeed bona fide risk factors for epilepsy.

Since VPA induces changes in the expression of many genes as an epigenetic drug ([@r40]), we initially assumed that the altered expression of numerous genes in NS/PCs induced by prenatal VPA exposure would be sustained until adulthood. However, that was not the case: Only one DEG at the embryonic stage (E15) persisted until the adult stage, even though there existed hundreds of DEGs in NS/PCs between control and VPA mice at each developmental stage (E15, P5, and 12w). These findings imply that transient transcriptome changes in NS/PCs in response to VPA exposure at the embryonic stage led directly or indirectly to the alteration of gene expression at later stages, eventually causing neurological defects in adulthood. Although the mechanisms underlying the alterations in the adult NS/PC transcriptome, including reduced *Cxcr4* expression in VPA mice, have yet to be elucidated, future studies such as analyzing the epigenetic profile of NS/PCs in mice treated with VPA during development should help to reveal them.

In addition to its effects on NS/PCs as shown in this study, VPA also influences the behavior of other cell types in the CNS. Previous reports have revealed that VPA suppresses inhibitory synaptic formation by repressing the expression of a vesicular GABA transporter and glutamate decarboxylases in neurons ([@r41], [@r42]). GABA, the principal inhibitory neurotransmitter, provides a counterbalance to neuronal excitation. If the balance tips toward excitation, it induces seizure. VPA is also thought to affect the synaptic excitatory/inhibitory balance indirectly by changing gene expression in astrocytes ([@r43]). Based on these findings, we cannot completely exclude the possibility that prenatal VPA exposure increases seizure susceptibility by altering the behavior of cells other than NS/PCs. Nevertheless, our observation that replenishing *Cxcr4* expression alone in NS/PCs was sufficient to overcome the aberrant migration of newborn neurons and the increased seizure sensitivity in VPA mice clearly demonstrates that VPA-increased seizure susceptibility is attributable to the dysfunction of NS/PCs.

Since GCs newly generated from NS/PCs are reported to become fully mature within 8 wk ([@r44]), we injected *Cxcr4*-expressing retroviruses into the DG of 4-wk-old VPA mice and analyzed them 8 wk later. We found that seizure susceptibility and ectopic neurogenesis were suppressed in these mice. Because retroviruses mainly infect proliferating NPCs rather than long-term dividing NSCs ([@r44]), we concluded that *Cxcr4* replenishment in NPCs was responsible for the proper migration of their progeny to the GCL, thereby counteracting VPA-enhanced seizure sensitivity; however, we cannot currently explain why only one injection of *Cxcr4*-expressing retroviruses into 4-wk-old mice was sufficient to overcome the detrimental effect of prenatal VPA exposure. It is possible that some long-term dividing NSCs were also infected by the retroviruses, thus perhaps continuously suppressing mislocalization of newly generated neurons.

Ectopic neurogenesis in the hippocampal DG is observed in epileptic patients ([@r17]). In addition, physical exercise is known to have therapeutic effects on patients with epilepsy ([@r45], [@r46]). However, the functional link between these processes and the underlying mechanisms has yet to be established. We have shown here that voluntary exercise normalizes the expression of cell migration-associated genes in adult NS/PCs, leading to decreased seizure susceptibility in VPA mice through restoration of abnormal neuronal migration. Cognitive deficiency is also associated with epilepsy ([@r47]). In this regard, we have reported previously that voluntary exercise improves hippocampal cognitive function in VPA mice ([@r27]). In agreement with these findings, ablation of aberrant neurogenesis in the adult mouse hippocampus is known to suppress cognitive decline and chronic seizure frequency ([@r15]), suggesting that recurrent seizure as well as memory deficits can be prevented by precisely controlling seizure-induced aberrant neurogenesis.

Our results in this study indicate that prenatal environmental insults such as exposure to AEDs induce long-lasting impairments in NS/PC behavior and lead to deficiencies in brain activity in the offspring, but also that these adverse effects can be reversed by a simple physical activity. Our findings should pave the way for therapeutic strategies to treat offspring who have experienced an unfavorable intrauterine environment including exposure to medical drugs.

Methods {#s7}
=======

No statistical methods were used to predetermine sample sizes, but our sample sizes correspond to those reported in previous publications ([@r48]). Statistical analysis was performed using GraphPad Prism software (GraphPad Software). Data distribution was assumed to be normal but this was not formally tested. Statistical analysis was done using unpaired *t* tests and one-way ANOVA with post hoc analysis using Tukey's multiple comparison test. Data from the 1-h trial of KA treatment were analyzed by two-way repeated-measures ANOVA, and post hoc analysis was done using Bonferroni's multiple comparison test. Data are presented as mean ± SEM. Results were considered significant when *P* ≤ 0.05.

All aspects of animal care and treatment were carried out according to the guidelines of the Experimental Animal Care Committee of Kyushu University.

Additional information is provided in [*SI Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental).

Supplementary Material
======================

We appreciate the technical assistance from the Research Support Center, Kyushu University Graduate School of Medical Sciences. We thank Y. Ohkawa for performing RNA sequencing and N. Hamazaki, H. Noguchi, S. Katada, and T. Imamura for discussions. This study is supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) from the Japan Agency for Medical Research and Development, grants from the "FUKUOKA" OBGYN Researcher's Charity Foundation Fund, The Clinical Research Promotion Foundation, and Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI) Grants 16H06527 and 17H01390 (to K.N.).

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, <https://www.ncbi.nlm.nih.gov/geo> (accession no. [GSE101239](GSE101239)).

This article contains supporting information online at [www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1716479115/-/DCSupplemental).

[^1]: Edited by Fred H. Gage, Salk Institute for Biological Studies, San Diego, CA, and approved February 28, 2018 (received for review September 19, 2017)

[^2]: Author contributions: A.S., T.M., and K.N. designed research; A.S., T.M., H.D., and Y.N. performed research; A.S. and T.M. contributed new reagents/analytic tools; A.S., T.M., K.K., and K.N. analyzed data; and A.S., T.M., and K.N. wrote the paper.

[^3]: ^1^A.S. and T.M. contributed equally to this work.
